San Carlos, CA, United States of America

Sanjeev Satyal

This inventor holds 33 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Cancer Therapeutics. Top assignees: Oncomed Pharmaceuticals, Inc., Ph Pharma Co., Ltd., Amgen Mountain View, Inc.. Active years: 2010-2023.

USPTO Granted Patents = 33 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 291(Granted Patents)


Location History:

  • San Carols, CA (US) (2010)
  • San Carlos, CA (US) (2010 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thailanstatin
Neutrophil Elastase
Cancer Diagnosis
Wnt Antagonists
Frizzled Receptors
Monoclonal Antibodies
NOTCH Receptors
Polynucleotides
c-MET Kinase
Solid Tumor Cells
Tumor Growth Inhibition
DDR1-binding Agents
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Sanjeev Satyal

Introduction: Sanjeev Satyal, a talented inventor based in San Carlos, CA, has made significant contributions to the field of technology through his creative and groundbreaking ideas.

Latest Patents: Sanjeev Satyal holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Sanjeev Satyal has successfully brought several inventions from concept to reality, revolutionizing industries and improving people's lives.

Collaborations: Throughout his career, Sanjeev Satyal has collaborated with leading tech companies, research institutions, and universities to further develop his inventions and bring them to the market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Sanjeev Satyal's dedication to innovation and his relentless pursuit of excellence have established him as a respected figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…